Literature DB >> 19861990

Imaging: PET-CT imaging in non-small-cell lung cancer.

Mark Levine, Jim Julian.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19861990     DOI： 10.1038/nrclinonc.2009.163

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  8 in total

1.  Health insurers and medical-imaging policy--a work in progress.

Authors:  John K Iglehart
Journal:  N Engl J Med       Date:  2009-03-05       Impact factor: 91.245

2.  Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.

Authors:  Gerarda J M Herder; Henk Kramer; Otto S Hoekstra; Egbert F Smit; Jan Pruim; Harm van Tinteren; Emile F Comans; Paul Verboom; Carin A Uyl-de Groot; Alle Welling; Marinus A Paul; Maarten Boers; Pieter E Postmus; Gerrit J Teule; Harry J M Groen
Journal:  J Clin Oncol       Date:  2006-03-27       Impact factor: 44.544

3.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

Authors:  R M Pieterman; J W van Putten; J J Meuzelaar; E L Mooyaart; W Vaalburg; G H Koëter; V Fidler; J Pruim; H J Groen
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

4.  Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

Authors:  Harm van Tinteren; Otto S Hoekstra; Egbert F Smit; Jan H A M van den Bergh; Ad J M Schreurs; Roland A L M Stallaert; Piet C M van Velthoven; Emile F I Comans; Fred W Diepenhorst; Paul Verboom; Johan C van Mourik; Pieter E Postmus; Maarten Boers; Gerrit J J Teule
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

5.  Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer.

Authors:  Rosalie C Viney; Michael J Boyer; Madeleine T King; Patricia M Kenny; Christine A Pollicino; Jocelyn M McLean; Brian C McCaughan; Michael J Fulham
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

6.  Preoperative staging of lung cancer with combined PET-CT.

Authors:  Barbara Fischer; Ulrik Lassen; Jann Mortensen; Søren Larsen; Annika Loft; Anne Bertelsen; Jesper Ravn; Paul Clementsen; Asbjørn Høgholm; Klaus Larsen; Torben Rasmussen; Susanne Keiding; Asger Dirksen; Oke Gerke; Birgit Skov; Ida Steffensen; Hanne Hansen; Peter Vilmann; Grete Jacobsen; Vibeke Backer; Niels Maltbaek; Jesper Pedersen; Henrik Madsen; Henrik Nielsen; Liselotte Højgaard
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

7.  Positron emission tomography in staging early lung cancer: a randomized trial.

Authors:  Donna E Maziak; Gail E Darling; Richard I Inculet; Karen Y Gulenchyn; Albert A Driedger; Yee C Ung; John D Miller; Chu-Shu Gu; Kathryn J Cline; William K Evans; Mark N Levine
Journal:  Ann Intern Med       Date:  2009-07-06       Impact factor: 25.391

Review 8.  18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.

Authors:  Yee C Ung; Donna E Maziak; Jessica A Vanderveen; Christopher A Smith; Karen Gulenchyn; Christina Lacchetti; William K Evans
Journal:  J Natl Cancer Inst       Date:  2007-11-27       Impact factor: 13.506
  8 in total
  1 in total

1.  FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography.

Authors:  Angelique Ale; Vladimir Ermolayev; Eva Herzog; Christian Cohrs; Martin Hrabé de Angelis; Vasilis Ntziachristos
Journal:  Nat Methods       Date:  2012-05-06       Impact factor: 28.547
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.